Medicinal perspective of quinazolinone derivatives: Recent developments and structure–activity relationship studies
Authors:
- 11 October 2021
- journal article
- review article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 59 (2) , 239-257
Abstract
Heterocyclic rings have long piqued the interest of medicinal chemists. Quinazolinone is a fused nitrogen‐based heterocyclic moiety. Some of quinazolinone derivatives have emerged as marketed drugs. A tremendous number of pharmacological activities such as anticancer, anticonvulsant, antimalarial, antifungal, antibacterial, antiinflammatory, MMP inhibitors, antidiabetic, antileishmanial, and hypolipidemic properties have been explored. A number of quinazolinone derivatives have already paved way in various stages of clinical trials. An extensive literature on developed synthetic schemes based on green chemistry and biological activities of quinazolinone has been included in this study. The content of patent filed and granted of various quinazolinone‐based compounds are also mentioned.Keywords
This publication has 82 references indexed in Scilit:
- Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungal activitiesEuropean Journal of Medicinal Chemistry, 2010
- Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine ringsEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivativesEuropean Journal of Medicinal Chemistry, 2009
- Quinazolinones and Pyrido[3,4-d]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of OsteoarthritisJournal of Medicinal Chemistry, 2008
- Synthesis and Evaluation of some Novel Quinazolinone Derivatives as Diuretic AgentsArchiv der Pharmazie, 2004
- DeferasiroxDrugs of the Future, 2004
- One-carbon compounds as synthetic intermediates. The synthesis of hydropyrimidines and hydroquinazolines by sequential nucleophilic addition to diphenyl cyanocarbonimidate with concomitant cyclizationThe Journal of Organic Chemistry, 1989
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983
- Derivate des o‐AmidobenzylalkoholsEuropean Journal of Inorganic Chemistry, 1889
- Ueber die Einwirkung des Cyans auf AnthranilsäureEuropean Journal of Inorganic Chemistry, 1869